- Release Date: 28/05/15 16:07
- Summary: RELINT: RYM: Disclosure of Director's Relevant Interests
- Price Sensitive: No
- Download Document 2.71KB
RYM 28/05/2015 16:07 RELINT NOT PRICE SENSITIVE REL: 1607 HRS Ryman Healthcare Limited RELINT: RYM: Disclosure of Director's Relevant Interests Disclosure of acquisition or disposal of relevant interest by director or senior manager Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To: NZX Limited And; Name of Listed Issuer: Ryman Healthcare Limited Date this disclosure made: 28 May 2015 Date of last disclosure: 25 November 2014 Director(s) or senior manager(s) giving disclosure Full name(s): Douglas Alexander McKay Name of listed issuer: Ryman Healthcare Limited Name of related body corporate (if applicable): N/A Position held in listed issuer: Director Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary shares in Ryman Healthcare Limited (NZX security code RYM) Nature of the affected relevant interest(s): Custodial Services Limited holds the shares as custodian for the McKay Family Trust Partnership, of which Douglas Alexander McKay is a beneficial owner. For that relevant interest,-- (a) number held in class before acquisition or disposal: 6,000 ordinary shares (b) number held in class after acquisition or disposal: 24,800 ordinary shares (c) current registered holder(s): Unknown (d) registered holder(s) once transfers are registered: Custodial Services Limited Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: Two Details of the transactions requiring disclosure: (1) Acquisition of 12,500 ordinary shares in an on-market trade agreed on 22 May 2015, for a total consideration of $100,375 ($8.03 per ordinary share). (2) Acquisition of 6,300 ordinary shares in an on-market trade agreed on 25 May 2015, for a total consideration of $49,581 ($7.87 per ordinary share). Ryman Healthcare Limited has a financial products trading policy that requires directors to seek prior written clearance from Ryman Healthcare Limited for trading by them or by trusts, companies and other entities controlled by them during certain closed periods. Clearance to acquire the shares was sought, and was granted in accordance with the policy, on 22 May 2015. Summary of other relevant interests after acquisition or disposal Class of quoted financial products: N/A Nature of relevant interest(s): N/A For that relevant interest,-- (a) number held in class: N/A (b) current registered holder(s): N/A Signature of person authorised to sign on behalf of director or officer Gordon MacLeod Deputy Chief Executive, Chief Financial Officer and Company Secretary Ryman Healthcare Limited Date of signature: 28 May 2015 End CA:00264961 For:RYM Type:RELINT Time:2015-05-28 16:07:35
- Forums
- NZX - By Stock
- Ann: RELINT: RYM: Disclosure of Director's Relevant Interests
Ann: RELINT: RYM: Disclosure of Director's Relevant Interests
Featured News
Add RYM (NZSX) to my watchlist
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online